86 related articles for article (PubMed ID: 6968915)
1. Pre- and postsynaptic serotonergic manipulations in an animal model of depression.
Nagayama H; Hingtgen JN; Aprison MH
Pharmacol Biochem Behav; 1980 Oct; 13(4):575-9. PubMed ID: 6968915
[TBL] [Abstract][Full Text] [Related]
2. Postsynaptic action by four antidepressive drugs in an animal model of depression.
Nagayama H; Hingtgen JN; Aprison MH
Pharmacol Biochem Behav; 1981 Jul; 15(1):125-30. PubMed ID: 6974869
[TBL] [Abstract][Full Text] [Related]
3. Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression.
Hingtgen JN; Hendrie HC; Aprison MH
Pharmacol Biochem Behav; 1984 Mar; 20(3):425-8. PubMed ID: 6608737
[TBL] [Abstract][Full Text] [Related]
4. Action of chronically administered antidepressants on the serotonergic postsynapse in a model of depression.
Nagayama H; Akiyoshi J; Tobo M
Pharmacol Biochem Behav; 1986 Oct; 25(4):805-11. PubMed ID: 3491369
[TBL] [Abstract][Full Text] [Related]
5. Potentiated 5-hydroxytryptophan induced response suppression in rats following chronic reserpine.
Brugge KL; Hingtgen JN; Aprison MH
Pharmacol Biochem Behav; 1987 Feb; 26(2):287-91. PubMed ID: 3495008
[TBL] [Abstract][Full Text] [Related]
6. Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats.
Rodríguez Echandía EL; Broitman ST; Fóscolo MR
Pharmacol Biochem Behav; 1983 Aug; 19(2):193-7. PubMed ID: 6605538
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
Fehrer SC; Silsby JL; El Halawani ME
Gen Comp Endocrinol; 1983 Dec; 52(3):400-8. PubMed ID: 6230284
[TBL] [Abstract][Full Text] [Related]
8. Interactions of histaminergic and serotonergic neurons in the hypothalamic regulation of prolactin and ACTH secretion.
Jørgensen H; Knigge U; Kjaer A; Warberg J
Neuroendocrinology; 1996 Nov; 64(5):329-36. PubMed ID: 8930933
[TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
Jørgensen H; Knigge U; Warberg J
Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
[TBL] [Abstract][Full Text] [Related]
10. Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857).
Hingtgen JN; Fuller RW; Mason NR; Aprison MH
Biol Psychiatry; 1985 Jun; 20(6):592-7. PubMed ID: 3873259
[TBL] [Abstract][Full Text] [Related]
11. Spinal cord injury-specific depression of monosynaptic spinal reflex transmission by l-5-hydroxytryptophan results from loss of the 5-HT uptake system and not 5-HT receptor supersensitivity.
Honda M; Tanabe M; Ono H
Exp Neurol; 2006 Nov; 202(1):258-61. PubMed ID: 16806182
[TBL] [Abstract][Full Text] [Related]
12. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
13. The influence of pharmacological manipulation of serotonin on serum growth hormone and luteinizing hormone levels in young turkeys (Meleagris gallopavo).
Fehrer SC; Silsby JL; Burke WH; el Halawani ME
Poult Sci; 1985 Jul; 64(7):1356-62. PubMed ID: 3161015
[TBL] [Abstract][Full Text] [Related]
14. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Feighner JP
J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
[TBL] [Abstract][Full Text] [Related]
15. Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal.
Kleven MS; Sparber SB
Psychopharmacology (Berl); 1989; 98(2):231-5. PubMed ID: 2474176
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
17. A controlled comparison of fluoxetine and amitriptyline in depressed out-patients.
Young JP; Coleman A; Lader MH
Br J Psychiatry; 1987 Sep; 151():337-40. PubMed ID: 3322468
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine affects rat migrating myoelectric complexes through different receptor subtypes: evidence from 5-hydroxytryptophan administration.
Sagrada A; Brancaccio N; Schiavone A
Life Sci; 1990; 46(17):1207-16. PubMed ID: 2338886
[TBL] [Abstract][Full Text] [Related]
19. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy.
Nicolodi M; Sicuteri F
Adv Exp Med Biol; 1996; 398():373-9. PubMed ID: 8906292
[TBL] [Abstract][Full Text] [Related]
20. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
Chouinard G
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
